Literature DB >> 4340235

Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.

F H Glorieux, C R Scriver, T M Reade, H Goldman, A Roseborough.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4340235     DOI： 10.1056/NEJM197209072871003

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

1.  Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Authors:  Erik A Imel; Francis H Glorieux; Michael P Whyte; Craig F Munns; Leanne M Ward; Ola Nilsson; Jill H Simmons; Raja Padidela; Noriyuki Namba; Hae Il Cheong; Pisit Pitukcheewanont; Etienne Sochett; Wolfgang Högler; Koji Muroya; Hiroyuki Tanaka; Gary S Gottesman; Andrew Biggin; Farzana Perwad; Meng Mao; Chao-Yin Chen; Alison Skrinar; Javier San Martin; Anthony A Portale
Journal:  Lancet       Date:  2019-05-16       Impact factor: 79.321

2.  X-linked hypophosphatemia: the mutant gene is expressed in teeth as well as in kidney.

Authors:  E D Shields; C R Scriver; T Reade; T M Fujiwara; K Morgan; A Ciampi; S Schwartz
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

3.  Updating genograms in the practice of preventive medicine.

Authors:  P W Allderdice; E O'Leary; S Ficken
Journal:  Can Fam Physician       Date:  1988-04       Impact factor: 3.275

4.  Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.

Authors:  Q L Huang; D S Feig; M E Blackstein
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

Review 5.  The William Allan Memorial Award address: On phosphate transport and genetic screening. "Understanding backward--living forward" in human genetics.

Authors:  C R Scriver
Journal:  Am J Hum Genet       Date:  1979-05       Impact factor: 11.025

6.  Orthophosphate transport in the erythrocyte of normal subjects and of patients with X-linked hypophosphatemia.

Authors:  H S Tenenhouse; C R Scriver
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

Review 7.  X-linked hypophosphataemia: a homologous phenotype in humans and mice with unusual organ-specific gene dosage.

Authors:  C R Scriver; H S Tenenhouse
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

8.  Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.

Authors:  M K Drezner; K W Lyles; M R Haussler; J M Harrelson
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  Healing of rickets with phosphate supplementation in the hypophosphatemic male mouse.

Authors:  P J Marie; R Travers; F H Glorieux
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

10.  Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.

Authors:  R M Harrell; K W Lyles; J M Harrelson; N E Friedman; M K Drezner
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.